HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rhian M Touyz Selected Research

1,4-dihydropyridine (dihydropyridine)

5/2014Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.
7/2011The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
5/2010The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2009The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
6/2008The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2007The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2006The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
6/2005The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rhian M Touyz Research Topics

Disease

153Hypertension (High Blood Pressure)
12/2023 - 01/2002
51Inflammation (Inflammations)
03/2024 - 12/2002
31Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 06/2002
23Fibrosis (Cirrhosis)
01/2023 - 06/2002
21Vascular Remodeling
12/2020 - 01/2002
18Neoplasms (Cancer)
06/2023 - 10/2009
17Stroke (Strokes)
11/2023 - 01/2002
17Vascular System Injuries
01/2022 - 05/2003
15Albuminuria
01/2022 - 06/2005
14Heart Failure
01/2021 - 06/2005
13Diabetic Nephropathies (Diabetic Nephropathy)
03/2024 - 06/2009
13Diabetes Mellitus
12/2019 - 02/2004
12Body Weight (Weight, Body)
12/2018 - 08/2003
12Hypertrophy
01/2017 - 05/2003
11Obesity
01/2023 - 06/2003
10Myocardial Infarction
10/2021 - 06/2005
8Chronic Renal Insufficiency
01/2016 - 06/2005
7COVID-19
01/2023 - 01/2020
7Vascular Diseases (Vascular Disease)
01/2023 - 03/2005
7Atherosclerosis
01/2021 - 05/2013
7Cardiomegaly (Heart Hypertrophy)
01/2020 - 10/2003
7Insulin Resistance
12/2018 - 06/2003
6Hyperaldosteronism (Conn Syndrome)
01/2019 - 02/2005
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 02/2007
6Isolated Systolic Hypertension
05/2010 - 06/2005
5Hyperglycemia
03/2024 - 10/2009
5Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2019 - 05/2007
5Type 2 Diabetes Mellitus (MODY)
12/2018 - 02/2004
5Vascular Calcification
01/2018 - 02/2009
4Pulmonary Arterial Hypertension
01/2023 - 01/2016
4Chronic Disease (Chronic Diseases)
10/2022 - 02/2009
4Pre-Eclampsia (Preeclampsia)
01/2022 - 05/2004
4Thrombosis (Thrombus)
03/2021 - 01/2016
4Dyslipidemias (Dyslipidemia)
09/2020 - 06/2005
4Necrosis
01/2020 - 10/2012
4Magnesium Deficiency (Deficiency, Magnesium)
07/2011 - 05/2004
3Pathologic Processes
12/2023 - 05/2004

Drug/Important Bio-Agent (IBA)

47Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 11/2002
38Angiotensin IIIBA
12/2022 - 10/2002
26SaltsIBA
01/2023 - 01/2002
25NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020 - 12/2002
23Proteins (Proteins, Gene)FDA Link
12/2023 - 11/2002
19MagnesiumIBA
10/2022 - 11/2002
18AldosteroneIBA
01/2022 - 08/2002
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2014
14Biomarkers (Surrogate Marker)IBA
11/2023 - 05/2012
14Phosphotransferases (Kinase)IBA
01/2023 - 11/2002
14AntioxidantsIBA
01/2021 - 01/2002
14Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020 - 06/2005
13Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023 - 08/2003
11Endothelin-1 (Endothelin 1)IBA
01/2023 - 06/2002
11CollagenIBA
01/2023 - 06/2002
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2007
11Angiotensin Receptor AntagonistsIBA
01/2020 - 06/2005
10Endothelins (Endothelin)IBA
01/2022 - 01/2003
10Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2021 - 06/2005
9Superoxides (Superoxide)IBA
01/2022 - 10/2003
9Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 06/2002
9Protein Isoforms (Isoforms)IBA
10/2020 - 03/2009
9LipidsIBA
12/2019 - 06/2005
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2019 - 06/2005
9CholesterolIBA
10/2015 - 06/2005
8AngiotensinsIBA
01/2023 - 12/2002
8Peptides (Polypeptides)IBA
01/2021 - 03/2005
81,4-dihydropyridine (dihydropyridine)IBA
05/2014 - 06/2005
7Angiogenesis InhibitorsIBA
01/2022 - 01/2018
7ThiazidesIBA
01/2017 - 06/2005
7Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2014 - 06/2005
6CytokinesIBA
03/2024 - 05/2007
6Vasoconstrictor AgentsIBA
09/2023 - 10/2004
6rho-Associated KinasesIBA
01/2021 - 04/2003
6Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2016 - 02/2008
6Dietary SodiumIBA
02/2014 - 05/2007
6Desoxycorticosterone Acetate (DOCA)FDA Link
04/2007 - 01/2003
5Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2018
5CationsIBA
01/2023 - 12/2010
5Estrogens (Estrogen)FDA Link
01/2022 - 09/2009
5Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2021 - 08/2004
5Streptozocin (Streptozotocin)FDA Link
10/2017 - 04/2014
5DiureticsIBA
09/2013 - 05/2007
4Monoclonal AntibodiesIBA
03/2024 - 01/2018
4Hormones (Hormone)IBA
02/2024 - 08/2014
4AndrogensIBA
09/2023 - 09/2007
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2023 - 03/2010
4Tyrosine (L-Tyrosine)FDA Link
01/2023 - 04/2003
4ReninIBA
01/2023 - 06/2003
4NADP (NADPH)IBA
01/2021 - 10/2005
4Fibronectins (Fibronectin)IBA
01/2020 - 02/2012
4MineralocorticoidsIBA
01/2020 - 10/2003
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2018 - 03/2009
4AdipokinesIBA
08/2018 - 08/2014
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 12/2013
4CalciumIBA
11/2016 - 02/2005
4Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
11/2016 - 05/2007
4Spironolactone (Aldactone)FDA LinkGeneric
10/2015 - 07/2003
4Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2015 - 02/2009
4Desoxycorticosterone (Deoxycorticosterone)IBA
04/2007 - 10/2003
3MicroRNAs (MicroRNA)IBA
03/2024 - 01/2018
3Testosterone (Sustanon)FDA Link
09/2023 - 06/2012

Therapy/Procedure

39Therapeutics
06/2023 - 05/2003